We expect Emmaus Life Sciences, Inc. (OTC:EMMA) to provide updates on its efforts to expand the presence of its key drug Endari throughout the global sickle cell disease (SCD) marketplace when it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results